Read + Share
Amedeo Smart
Independent Medical Education
Ou SI, Kim ES. Response to: Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population? J Thorac Oncol 2023;18:e30-e31.PMID: 36842818
Email
LinkedIn
Facebook
Twitter
Privacy Policy